Mechanical prosthetic aortic valve thrombosis treated with low-dose ultra slow infusion of tissue-type plasminogen activator during pregnancy

Ural, Ülkü MeteUysal, AybikeErdal, Emrah2023-05-262023-05-262021Ural, U. M., Uysal, A., & Erdal, E. (2021). Mechanical Prosthetic Aortic Valve Thrombosis Treated with Low-dose Ultra Slow Infusion of Tissue-type Plasminogen Activator during Pregnancy. Journal of the College of Physicians and Surgeons Pakistan, 31(3), 369-371.1022-386X1681-7168http://dx.doi.org/10.29271/jcpsp.2021.03.369https://hdl.handle.net/20.500.12491/10975Sir, Prosthetic valve thrombosis (PVT) is extremely rare in patients with aortic valve replacement and can be a life-threatening condition for both the mother and fetus, if it develops in pregnant women; and it requires immediate treatment. The treatment options during pregnancy include valve replacement, surgical thrombectomy, and thrombolytic therapy.1 The surgical approach in pregnancy is associated with elevated maternal and fetal mortalityeninfo:eu-repo/semantics/openAccessThrombusPlasminogenMechanical prosthetic aortic valve thrombosis treated with low-dose ultra slow infusion of tissue-type plasminogen activator during pregnancyLetter10.29271/jcpsp.2021.03.369313369370337750402-s2.0-85103531804Q3WOS:000630478200032Q4